| (AUD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 735.75M | -0.74% |
| Operating expense | — | — |
| Net income | 23.71M | -26.89% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ACL.AX returned +25.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +10.6% |
| 1 year | +25.2% |
| 5 years | -13.8% |
| All-time high | $6.20 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ACL.AX would be worth today ›Yes. Australian Clinical Labs Limited paid 2 dividends over the past 12 months. The most recent was $0.04 per share on Mar 12, 2026. The dividend yield is 4.35%.
Australian Clinical Labs Limited is part of the Healthcare sector.
Australian Clinical Labs Limited has a market cap of 557.69M AUD, based on the latest quote.